Alivus Life Sciences Schedules Institutional Investor Meetings in Mumbai
Alivus Life Sciences Ltd 路 Intimation 路 30 Oct 2026, 11:24 pm
Alivus Life Sciences Schedules Institutional Investor Meetings in Mumbai Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has scheduled in-person, one-on-one investor and analyst meetings in Mumbai under SEBI LODR Regulation 30. The company's representatives will meet with Edelweiss Mutual Fund and Steinberg Asset Management on 4th Nov'26, followed by meetings with Axis Max Life Insurance and Karma Capital on 6th Nov'26. The schedule and meeting mode remain subject to change based on exigencies from either party.
Original exchange filing (PDF)
More announcements from Alivus Life Sciences Ltd
- Enclosed please find herewith update on acquisition. 路 11 Nov 2026
- Please find enclosed herewith disclosure under Regulation 30 of SEBI(LODR), 2015. 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirma Ltd 路 07 Nov 2026
- Please find attached herewith submission with respect to transcript of the earning call. 路 06 Nov 2026
- Please find enclosed herewith intimation for Analyst/Investor meeting. 路 04 Nov 2026
- We hereby confirm that we have uploaded audio recording of the Q2 FY2027 Earnings Call held on October 30, 2026 on the website of the Company. 路 30 Oct 2026
- Please find enclosed herewith intimation with respect to allotment of equity shares under "Employee Stock Option Scheme, 2021" 路 30 Oct 2026
- Please find enclosed herewith Investor Presentation for Q2 FY26-27. 路 30 Oct 2026
